1-β-d-arabinofuranosylcytosine-, mitoxantrone-, and paclitaxel-induced apoptosis in HL-60 cells: improved method for detection of internucleosomal DNA fragmentation

Cancer Chemotherapy and Pharmacology

Volumn 34, Issue 5, 1994, Pages 365-371

  Ray, Swapan ^a   Ponnathpur, Vidya ^a   Huang, Yue ^a   Tang, Caroline ^a   Mahoney, Mary Ella ^a   Ibrado, Ana Maria ^a   Bullock, Gloria ^a   Bhalla, Kapil ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Apoptosis; Ara C; DNA fragmentation; HL 60 cells; Mitoxantrone; Taxol

Indexed keywords

CYTARABINE; DNA FRAGMENT; MITOXANTRONE; PACLITAXEL;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; CELL CULTURE; CELL STRAIN HL 60; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DOSE TIME EFFECT RELATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MICROSCOPY; NUCLEOSOME; PRIORITY JOURNAL; TECHNIQUE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CYTARABINE; DNA DAMAGE; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ELECTROPHORESIS, AGAR GEL; GENOME, HUMAN; HUMAN; LEUKEMIA, MYELOCYTIC, ACUTE; MITOXANTRONE; PACLITAXEL; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0028167771     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/BF00685559     Document Type: Article

References (42)

1. Phase I clinical trial of mitoxantrone: a new anthracenedione anticancer drug
2. Apoptosis. The role of endonuclease
3. Lederle Cooperative Group: randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL)
4. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia
5. GM-CSF/IL-3 fusion protein (PIXY 321) enhances high dose Ara-C induced programmed cell death or apoptosis in human myeloid leukemic cells
6. Isolation and characterization of taxol resistant human myeloid leukemia cells
7. High-dose mitoxantrone induces programmed cell death or apoptosis in human myeloid leukemia cells
8. Taxol induces internuleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells
9. bcl-x, A bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
10. High dose cytarabine: a review
11. Comparative molecular pharmacology in leukemic L1210 cells of the anthracene anticancer drugs mitoxantrone and bisantrene
12. Effect of combined treatment with interleukin-3 and interleukin-6 on 4-hydroperoxycyclophosphamide induced programmed cell death or apoptosis in human myeloid cells
13. Cytosine arabinoside
14. Acute myelogenous leukemia: recent advances in therapy
15. Thymocyte apoptosis induced by p53-dependent and independent pathways
16. Continuous growth and differentiation of human myeloid cells in suspension culture
17. A biochemical hallmark of apoptosis: internucleosomal degradation of the genome
18. Mitoxantrone affects topoisomerase activities in human breast cancer cells
19. Drug-target interactions: only the first step in the commitment to a programmed cell death?
20. Induction of apoptosis — new targets for cancer chemotherapy
21. The origin of DNA breaks: a consequence of DNA damage, DNA repair, or apoptosis
22. bcl-2 Modulation of apoptosis induced by anticancer drugs; resistance to thymidylate stress is independent of classical resistance pathways
23. Effect of pharmacologically relevant concentrations of mitoxantrone on the in vitro growth of leukemic blast progenitors
24. Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-β- d-arabinofuranosylcytosine
25. Apoptosis induced by anticancer drugs
26. Mitoxantrone-induced toxicity and DNA strand breaks in leukemic cells
27. A quantitative assay for fragmented DNA in apoptotic cells
28. Induction of endonucleotylic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note
29. Correlation of cytotoxicity with incorporation of ara-C into DNA
30. “Thymineless” death in androgen-independent prostatic cancer cells
31. Taxol: an antimitotic agent with a new mechanism of action
32. Relationship between DNA cross-links, cell cycle and apoptosis in Burkitt's lymphoma cell lines differing in sensitivity to nitrogen mustard
33. bcl-2 Heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death
34. Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol
35. Phase I and pharmacodynamic study of taxol in refractory acute leukemias
36. Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors
37. Calyculin A, a potent inhibitor of phosphatases-1 and-2A, prevents apoptosis
38. Constitutive expression of human bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis
39. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia
40. Apoptosis or programmed cell death
41. Molecular regulation of apoptosis: genetic controls on cell death
42. Apoptosis: cell death in tissue regulation